(Q38047077)

27 August 2017

title

Regulators of innate immunity as novel targets for panviral therapeutics (English)

1 reference

27 August 2017

Nicolas Tremblay

2

0 references

Daniel Lamarre

series ordinal

4

object named as

Daniel Lamarre

1 reference

27 August 2017

3

Martin Baril

1 reference

27 August 2017

1

Salwa Es-Saad

1 reference

27 August 2017

publication date

25 September 2012

1 reference

Current opinion in virology

27 August 2017

published in

1 reference

27 August 2017

volume

2

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

622-628

1 reference

Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells

27 August 2017

cites work

1 reference

12 December 2020

A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits

1 reference

12 December 2020

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin

1 reference

12 December 2020

Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis.

1 reference

12 December 2020

Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions

1 reference

12 December 2020

Current and future treatment options for HCV.

1 reference

12 December 2020

RIG-I-like receptors: cytoplasmic sensors for non-self RNA.

1 reference

12 December 2020

Interferon-lambda: a new addition to an old family

1 reference

12 December 2020

Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication

1 reference

12 December 2020

Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix

1 reference

12 December 2020

The yin and yang of viruses and interferons

1 reference

12 December 2020

Vaccine adjuvants: scientific challenges and strategic initiatives

1 reference

12 December 2020

Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist

1 reference

12 December 2020

Structural Insights into RNA Recognition by RIG-I

1 reference

12 December 2020

Triggering TLR signaling in vaccination

1 reference

12 December 2020

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

1 reference

12 December 2020

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults

1 reference

12 December 2020

Pattern recognition receptors and inflammation

1 reference

12 December 2020

The structural biology of Toll-like receptors

1 reference

12 December 2020

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

12 December 2020

New hepatitis B vaccine formulated with an improved adjuvant system

1 reference

12 December 2020

Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta.

1 reference

12 December 2020

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

1 reference

12 December 2020

RIG-I like receptors in antiviral immunity and therapeutic applications

1 reference

12 December 2020

Viral and cellular microRNAs as determinants of viral pathogenesis and immunity

1 reference

12 December 2020

RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity.

1 reference

12 December 2020

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production

1 reference

12 December 2020

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

1 reference

12 December 2020

Dissecting negative regulation of Toll-like receptor signaling

1 reference

12 December 2020

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

1 reference

12 December 2020

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity

1 reference

12 December 2020

Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model

1 reference

12 December 2020

Structural basis of RNA recognition and activation by innate immune receptor RIG-I

1 reference

12 December 2020

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

1 reference

12 December 2020

Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies

1 reference

12 December 2020

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV.

1 reference

12 December 2020

Regulation of RLR-mediated innate immune signaling--it is all about keeping the balance

1 reference

12 December 2020

Direct effects of type I interferons on cells of the immune system

1 reference

12 December 2020

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 December 2020

Albinterferon-alpha 2b: a new treatment option for hepatitis C.

1 reference

12 December 2020

Poly(I:C) and Lipopolysaccharide Innate Sensing Functions of Circulating Human Myeloid Dendritic Cells Are Affected In Vivo in Hepatitis C Virus-Infected Patients

1 reference

12 December 2020

Targeting of Toll-like receptors: a decade of progress in combating infectious diseases

1 reference

12 December 2020

A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvant

1 reference

12 December 2020

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine

1 reference

12 December 2020

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

1 reference

12 December 2020

Immune signaling by RIG-I-like receptors

1 reference

12 December 2020

Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease

1 reference

12 December 2020

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

1 reference

12 December 2020

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases

1 reference

12 December 2020

Antiviral applications of Toll-like receptor agonists.

1 reference

12 December 2020

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response

1 reference

12 December 2020

MicroRNAs: the fine-tuners of Toll-like receptor signalling

1 reference

12 December 2020

10.1016/J.COVIRO.2012.08.009

Identifiers

DOI

1 reference

27 August 2017

0 references

1 reference